LPL Financial’s Humacyte HUMA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.51M | Buy |
724,800
+90,818
| +14% | +$190K | ﹤0.01% | 3356 |
|
2025
Q1 | $1.08M | Buy |
633,982
+103,990
| +20% | +$177K | ﹤0.01% | 3460 |
|
2024
Q4 | $2.68M | Buy |
529,992
+18,000
| +4% | +$90.9K | ﹤0.01% | 2587 |
|
2024
Q3 | $2.79M | Buy |
511,992
+48,740
| +11% | +$265K | ﹤0.01% | 2410 |
|
2024
Q2 | $2.22M | Buy |
463,252
+43,157
| +10% | +$207K | ﹤0.01% | 2490 |
|
2024
Q1 | $1.31M | Buy |
420,095
+52,550
| +14% | +$163K | ﹤0.01% | 2913 |
|
2023
Q4 | $1.04M | Buy |
367,545
+26,063
| +8% | +$74K | ﹤0.01% | 2983 |
|
2023
Q3 | $1M | Buy |
341,482
+25,342
| +8% | +$74.3K | ﹤0.01% | 2869 |
|
2023
Q2 | $904K | Buy |
316,140
+37,300
| +13% | +$107K | ﹤0.01% | 2896 |
|
2023
Q1 | $862K | Sell |
278,840
-5,700
| -2% | -$17.6K | ﹤0.01% | 2851 |
|
2022
Q4 | $600K | Sell |
284,540
-28,500
| -9% | -$60.1K | ﹤0.01% | 3076 |
|
2022
Q3 | $1.02M | Buy |
313,040
+15,500
| +5% | +$50.6K | ﹤0.01% | 2523 |
|
2022
Q2 | $955K | Buy |
+297,540
| New | +$955K | ﹤0.01% | 2600 |
|
2022
Q1 | – | Sell |
-238,865
| Closed | -$1.73M | – | 4270 |
|
2021
Q4 | $1.73M | Buy |
238,865
+124,250
| +108% | +$901K | ﹤0.01% | 2191 |
|
2021
Q3 | $1.33M | Buy |
+114,615
| New | +$1.33M | ﹤0.01% | 2374 |
|